Search

Your search keyword '"Sharkey R"' showing total 428 results

Search Constraints

Start Over You searched for: Author "Sharkey R" Remove constraint Author: "Sharkey R"
428 results on '"Sharkey R"'

Search Results

1. Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study

2. 504P SARS-CoV-2 Omicron (B.1.1.529) variant infection leads to high morbidity and mortality in unvaccinated patients with cancer

3. Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe

4. Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

5. Integrating On Campus Problem Based Learning and Practice Based Learning: Issues and Challenges in Using Computer Mediated Communication.

9. 1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19

12. Clinical portrait of the SARS-Cov-2 epidemic in European cancer patients

14. 1671MO Provision of palliative care for patients with cancer and SARS-CoV-2 infection

15. Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study

16. PULMONARY EMBOLISM: A CASE REQUIRING RESCUE PERCUTANEOUS INTERVENTION

17. Irish Thoracic Society: Proceedings of Annual Scientific Meeting held in Dublin on 4th & 5th November, 1994

18. National scientific medical meeting 1995 abstracts: Oral presentations

19. Irish thoracic society: Proceedings of annual scientific meeting held in Cork on 5th & 6th November, 1993

31. Readers' Pulse

34. Sacituzumab govitecan (IMMU-132) for patients with pretreated metastatic urothelial uancer (UC): interim results

41. P-162 Interim Results of IMMU-132 (Sacituzumab Govitecan), an Anti-Trop-2 Antibody-Drug Conjugate (ADC), in Patients (pts) with Metastatic Gastrointestinal (GI) Cancers

Catalog

Books, media, physical & digital resources